Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, 43400 UPM Serdang, Selangor, Malaysia.
BMC Complement Altern Med. 2013 Feb 14;13:32. doi: 10.1186/1472-6882-13-32.
Bixa orellana L. has been traditionally used in Central and South America to treat a number of ailments, including internal inflammation, and in other tropical countries like Malaysia as treatment for gastric ulcers and stomach discomfort. The current study aimed to determine the major chemical constituents of the aqueous extract of B. orellana (AEBO) and to evaluate the antihistamine activity of AEBO during acute inflammation induced in rats.
Acute inflammation was produced by subplantar injection of 0.1 mL of 0.1% histamine into the right hind paw of each rat in the control and treatment groups. The degree of edema was measured before injection and at the time points of 30, 60, 120, 180, 240 and 300 min after injection. Changes of peritoneal vascular permeability were studied using Evans blue dye as a detector. Vascular permeability was evaluated by the amount of dye leakage into the peritoneal cavity in rats. To evaluate the inhibitory effect of AEBO on biochemical mediators of vascular permeability, the levels of nitric oxide (NO) and vascular endothelial growth factor (VEGF) were determined in histamine-treated paw tissues. The major constituents of AEBO were determined by gas chromatography-mass spectrometry (GC-MS) analysis.
AEBO produced a significant inhibition of histamine-induced paw edema starting at 60 min time point, with maximal percentage of inhibition (60.25%) achieved with a dose of 150 mg/kg of AEBO at 60 min time point. Up to 99% of increased peritoneal vascular permeability produced by histamine was successfully suppressed by AEBO. The expression of biochemical mediators of vascular permeability, NO and VEGF, was also found to be downregulated in the AEBO treated group. Gas chromatography-mass spectrometry (GC-MS) analysis revealed that the major constituent in AEBO was acetic acid.
The experimental findings demonstrated that the anti-inflammatory activity of AEBO was due to its inhibitory effect on vascular permeability, which was suppressed as a result of the reduced expression of biochemical mediators (NO and VEGF) in tissues. Our results contribute towards the validation of the traditional use of Bixa orellana in the treatment of inflammatory disorders.
胭脂树在中美洲和南美洲传统上被用于治疗多种疾病,包括内部炎症,在马来西亚等其他热带国家被用于治疗胃溃疡和胃部不适。本研究旨在确定胭脂树水提物(AEBO)的主要化学成分,并评价 AEBO 在大鼠急性炎症中的抗组胺活性。
在对照组和治疗组大鼠的右后爪皮下注射 0.1ml0.1%组胺,引起急性炎症。在注射前和注射后 30、60、120、180、240 和 300 分钟测量水肿程度。使用 Evans 蓝染料作为指示剂研究腹膜血管通透性的变化。通过染料漏入腹腔的量评估大鼠腹膜血管通透性。为了评估 AEBO 对血管通透性生化介质的抑制作用,测定组胺处理后爪组织中一氧化氮(NO)和血管内皮生长因子(VEGF)的水平。通过气相色谱-质谱(GC-MS)分析确定 AEBO 的主要成分。
AEBO 对组胺诱导的爪水肿有显著的抑制作用,从 60 分钟时间点开始,在 60 分钟时间点用 150mg/kg 的 AEBO 剂量抑制率最大(60.25%)。AEBO 成功抑制了组胺引起的 99%的腹膜血管通透性增加。AEBO 治疗组血管通透性生化介质 NO 和 VEGF 的表达也下调。气相色谱-质谱(GC-MS)分析表明,AEBO 的主要成分为乙酸。
实验结果表明,AEBO 的抗炎活性是由于其对血管通透性的抑制作用,这是由于组织中生化介质(NO 和 VEGF)表达减少所致。我们的结果为胭脂树在治疗炎症性疾病中的传统应用提供了验证。